TY - JOUR
T1 - Rapid and profound rewiring of brain lipid signaling networks by acute diacylglycerol lipase inhibition
AU - Ogasawara, Daisuke
AU - Deng, Hui
AU - Viader, Andreu
AU - Baggelaar, Marc P
AU - Breman, Arjen
AU - den Dulk, Hans
AU - van den Nieuwendijk, Adrianus M C H
AU - Soethoudt, Marjolein
AU - van der Wel, Tom
AU - Zhou, Juan
AU - Overkleeft, Herman S
AU - Sanchez-Alavez, Manuel
AU - Mori, Simone
AU - Nguyen, William
AU - Conti, Bruno
AU - Liu, Xiaojie
AU - Chen, Yao
AU - Liu, Qing-Song
AU - Cravatt, Benjamin F
AU - van der Stelt, Mario
PY - 2016/1/5
Y1 - 2016/1/5
N2 - Diacylglycerol lipases (DAGLα and DAGLβ) convert diacylglycerol to the endocannabinoid 2-arachidonoylglycerol. Our understanding of DAGL function has been hindered by a lack of chemical probes that can perturb these enzymes in vivo. Here, we report a set of centrally active DAGL inhibitors and a structurally related control probe and their use, in combination with chemical proteomics and lipidomics, to determine the impact of acute DAGL blockade on brain lipid networks in mice. Within 2 h, DAGL inhibition produced a striking reorganization of bioactive lipids, including elevations in DAGs and reductions in endocannabinoids and eicosanoids. We also found that DAGLα is a short half-life protein, and the inactivation of DAGLs disrupts cannabinoid receptor-dependent synaptic plasticity and impairs neuroinflammatory responses, including lipopolysaccharide-induced anapyrexia. These findings illuminate the highly interconnected and dynamic nature of lipid signaling pathways in the brain and the central role that DAGL enzymes play in regulating this network.
AB - Diacylglycerol lipases (DAGLα and DAGLβ) convert diacylglycerol to the endocannabinoid 2-arachidonoylglycerol. Our understanding of DAGL function has been hindered by a lack of chemical probes that can perturb these enzymes in vivo. Here, we report a set of centrally active DAGL inhibitors and a structurally related control probe and their use, in combination with chemical proteomics and lipidomics, to determine the impact of acute DAGL blockade on brain lipid networks in mice. Within 2 h, DAGL inhibition produced a striking reorganization of bioactive lipids, including elevations in DAGs and reductions in endocannabinoids and eicosanoids. We also found that DAGLα is a short half-life protein, and the inactivation of DAGLs disrupts cannabinoid receptor-dependent synaptic plasticity and impairs neuroinflammatory responses, including lipopolysaccharide-induced anapyrexia. These findings illuminate the highly interconnected and dynamic nature of lipid signaling pathways in the brain and the central role that DAGL enzymes play in regulating this network.
KW - Animals
KW - Arachidonic Acids/metabolism
KW - Brain/drug effects
KW - Diglycerides/metabolism
KW - Endocannabinoids/metabolism
KW - Enzyme Inhibitors/chemistry
KW - Glycerides/metabolism
KW - Lipoprotein Lipase/antagonists & inhibitors
KW - Male
KW - Mice
KW - Mice, Inbred C57BL
KW - Neuronal Plasticity/drug effects
KW - Receptors, Cannabinoid/metabolism
KW - Signal Transduction/drug effects
U2 - 10.1073/pnas.1522364112
DO - 10.1073/pnas.1522364112
M3 - Article
C2 - 26668358
SN - 0027-8424
VL - 113
SP - 26
EP - 33
JO - Proceedings of the National Academy of Sciences of the United States of America
JF - Proceedings of the National Academy of Sciences of the United States of America
IS - 1
ER -